Morgan Stanley’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.76M | Sell |
2,224,829
-777,021
| -26% | -$2.8M | ﹤0.01% | 3786 |
|
|
2025
Q4 | $10.3M | Buy |
3,001,850
+209,708
| +8% | +$936K | ﹤0.01% | 3587 |
|
|
2025
Q3 | $14M | Buy |
2,792,142
+1,795,215
| +180% | +$7.91M | ﹤0.01% | 3241 |
|
|
2025
Q2 | $3.42M | Sell |
996,927
-294,089
| -23% | -$732K | ﹤0.01% | 4358 |
|
|
2025
Q1 | $2.88M | Buy |
1,291,016
+353,631
| +38% | +$1.01M | ﹤0.01% | 4360 |
|
|
2024
Q4 | $2.75M | Buy |
937,385
+347,732
| +59% | +$968K | ﹤0.01% | 4467 |
|
|
2024
Q3 | $1.53M | Buy |
589,653
+37,523
| +7% | +$104K | ﹤0.01% | 4798 |
|
|
2024
Q2 | $1.63M | Buy |
552,130
+161,991
| +42% | +$613K | ﹤0.01% | 4678 |
|
|
2024
Q1 | $1.77M | Sell |
390,139
-363,641
| -48% | -$1.86M | ﹤0.01% | 4665 |
|
|
2023
Q4 | $4.3M | Buy |
753,780
+172,365
| +30% | +$799K | ﹤0.01% | 4462 |
|
|
2023
Q3 | $2.67M | Sell |
581,415
-600,731
| -51% | -$3.65M | ﹤0.01% | 4198 |
|
|
2023
Q2 | $7.64M | Buy |
1,182,146
+272,742
| +30% | +$1.86M | ﹤0.01% | 3424 |
|
|
2023
Q1 | $6.86M | Buy |
909,404
+273,870
| +43% | +$2.49M | ﹤0.01% | 3498 |
|
|
2022
Q4 | $6.44M | Sell |
635,534
-67,476
| -10% | -$779K | ﹤0.01% | 3510 |
|
|
2022
Q3 | $6.95M | Buy |
703,010
+224,007
| +47% | +$2.46M | ﹤0.01% | 3353 |
|
|
2022
Q2 | $5.1M | Buy |
479,003
+85,867
| +22% | +$727K | ﹤0.01% | 3743 |
|
|
2022
Q1 | $3.83M | Sell |
393,136
-107,834
| -22% | -$1.02M | ﹤0.01% | 3965 |
|
|
2021
Q4 | $7.17M | Sell |
500,970
-235,049
| -32% | -$3.57M | ﹤0.01% | 3329 |
|
|
2021
Q3 | $14.8M | Buy |
736,019
+161,826
| +28% | +$2.86M | ﹤0.01% | 2427 |
|
|
2021
Q2 | $12.6M | Buy |
574,193
+501,828
| +693% | +$13.8M | ﹤0.01% | 2711 |
|
|
2021
Q1 | $2.46M | Buy |
72,365
+69,415
| +2,353% | +$2.77M | ﹤0.01% | 4102 |
|
|
2020
Q4 | $118K | Buy |
+2,950
| New | +$135K | ﹤0.01% | 5841 |
|
Other funds holding ABCL
BBA
TWC
ACH
DCM
